Local Institution

Mumbai, Maharashtra 400052

0 studies enrolling now · 9 studies all time

What they study most

Acute Coronary Syndrome, Atrial Fibrillation, Chronic Kidney Failure, Crohn's Disease, Depression, Kidney Transplantation, Leukemia, Prostatic Neoplasms, Ulcerative Colitis

Studies at this site

• A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML) or With Ph+ Leukemias Resistant or Intolerant to Imatinib — Completed
• Dose Ranging Study of BMS-945429 in Subjects With Moderate to Severe Crohn's Disease — Stopped early
• A Phase III Study of Apixaban in Patients With Atrial Fibrillation — Completed
• Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate Cancer — Completed
• Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT) — Completed
• Phase III Acute Coronary Syndrome — Stopped early
• Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression — Stopped early
• Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression — Completed
• A Study of Abatacept in Patients With Active Ulcerative Colitis — Completed